Connecticut Approves 6 New Medical Conditions For MMJ
Six new medical conditions are now approved for medical marijuana treatment in Connecticut as of Monday. As a result of petitions and public hearings, the Department of Consumer Protection's Board of Physicians now agree to acknowledge that more patients with serious health conditions should receive medical marijuana treatment.
The new conditions that are eligible for cannabis treatment are:
- sickle cell disease
- post-laminectomy syndrome
- chronic radiculopathy
- severe psoriasis and psoriatic arthritis
- amyotrophic lateral sclerosis (Lou Gehrig's disease)
- ulcerative colitis
- complex regional pain syndrome
"We're pleased that more people with serious diseases will have access to medicine that can help them with pain, with symptoms and their underlying disease conditions," said Jonathan Harris, state Consumer Protection Commissioner.
The Public Health Committee has also received a bill that will make easier access for hospice patients to get medical marijuana as well as legalize it for children with certain diseases. Those patients would be limited to "terminal illness requiring end-of-life care, irreversible spinal cord injury with objective neurological indication of intractable spasticity, cerebral palsy, cystic fibrosis, severe epilepsy or uncontrolled intractable seizure disorder."
The bill "also would make some important changes to step up research in Connecticut," Harris continued to say. With that being said, Connecticut could become the focal point for cannabis research nationwide.
As of this week, there are 9,310 patients registered with the state to buy medical marijuana from one of the six dispensaries currently in operation. Three more dispensaries are expected to open by this summer.